| 1 |
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Lung Disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med 2017;195:557-82.
DOI
|
| 2 |
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55.
DOI
|
| 3 |
Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122.
DOI
|
| 4 |
Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
DOI
|
| 5 |
Gedebjerg A, Szepligeti SK, Wackerhausen LH, Horvath-Puho E, Dahl R, Hansen JG, et al. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study. Lancet Respir Med 2018;6:204-12.
DOI
|
| 6 |
Menezes AM, Wehrmeister FC, Perez-Padilla R, Viana KP, Soares C, Mullerova H, et al. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017. Int J Chron Obstruct Pulmon Dis 2017;12:1491-501.
DOI
|
| 7 |
Candemir I, Ergun P, Kaymaz D, Tasdemir F, Egesel N. The comparison of clinical variables in two classifications: GOLD 2017 combined assessment and spirometric stage of chronic obstructive pulmonary disease. Tuberc Respir Dis 2018;81:281-8.
DOI
|
webmaster
